Products with sales of less than $25ꯠ have an additional year to comply. In studying the matter, the Food and Drug Administration said it learned that OTC drug manufacturers routinely redesign their product labels as part of their customary business practices, so the majority of manufacturers will be able to comply with the new format regulations with no additional paperwork or economic burdens. The agency estimated that approximately 32% of the drugs would need to be relabeled ahead of their customary redesign schedule. Manufacturers holding new drug applications and abbreviated new drug applications also may need to change their labeling. In all cases, it will be a one-time burden, according to FDA.
OTC labeling
April 16, 2002, was the compliance date for OTC drug packages to bear the standardized format and content requirements established by FDA on March 17, 1999.
Apr 30, 2002
Recommended
Recommended
Machinery Basics
2024 PACK EXPO Innovations Reports
Exclusive access: Packaging World editor-curated reports revealing PACK EXPO's most groundbreaking technologies across food, healthcare, and machinery sectors. Each report features truly innovative solutions selected from hundreds of exhibitors by our expert team. Transform your operations with just one click.
Access Now
Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—<i>Packaging World</i> editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now
